Table 3.

Patient characteristics by surgery groups.

Treatment group	RT	FT	FT + ISBS	P α	P β	P γ
Number of patients, n	54	33	28	/	/	/
Age, yr (mean ± SD)	43.5 ± 6.7	47.1 ± 7.3	45.4 ± 5.5	NS	NS	NS
Gender ratio,(F:M)	34:20	23:10	19:9	NS	NS	NS
Child-Pugh class (A:B)	19:35	8:24	6:22	NS	NS	NS
Spleen longitudinal diameter, cm	20.4 ± 3.7	21.8 ± 4.5	22.7 ± 5.2	NS	NS	NS
Hb, g/L	9.6 ± 0.9	9.3 ± 1.1	8.9 ± 1.4	NS	NS	NS
TBil, μmol/L	36.5 ± 7.6	40.6 ± 7.3	37.9 ± 8.7	NS	NS	NS
IBil, μmol/L	27.3 ± 5.7	30.1 ± 7.7	28.5 ± 7.9	NS	NS	NS
AST, U/L	235.2 ± 93.6	259.7 ± 80.5	190.1 ± 100.1	NS	NS	NS
ALT, U/L	472.1 ± 174.5	500.1 ± 220.5	450.6 ± 191.2	NS	NS	NS

Haemoglobin = Hb; F = female; M = male;TBil = Total bilirubin; IBil = Indirect bilirubin; AST = glutamic oxalacetic transaminase; ALT = glutamic-pyruvic transaminase; NS = not significant.

P^α FT group comparring to TR group, <0.05 has statistical significance*;

P^βFT + ISBS group comparring to RT group, <0.05 has statistical significance†;

P^γFT + ISBS group comparring to FT group, <0.05 has statistical significance§.